Literature DB >> 33850179

Anti-Acanthamoeba synergistic effect of chlorhexidine and Garcinia mangostana extract or α-mangostin against Acanthamoeba triangularis trophozoite and cyst forms.

Suthinee Sangkanu1, Watcharapong Mitsuwan1,2, Wilawan Mahabusarakam3, Tajudeen O Jimoh4,5, Polrat Wilairatana6, Ana Paula Girol7, Ajoy K Verma8, Maria de Lourdes Pereira9, Mohammed Rahmatullah10, Christophe Wiart11, Abolghasem Siyadatpanah12, Roghayeh Norouzi13, Polydor Ngoy Mutombo14,15, Veeranoot Nissapatorn16.   

Abstract

Acanthamoeba spp. can cause amoebic keratitis (AK). Chlorhexidine is effective for AK treatment as monotherapy, but with a relative failure on drug bioavailability in the deep corneal stroma. The combination of chlorhexidine and propamidine isethionate is recommended in the current AK treatment. However, the effectiveness of treatment depends on the parasite and virulence strains. This study aims to determine the potential of Garcinia mangostana pericarp extract and α-mangostin against Acanthamoeba triangularis, as well as the combination with chlorhexidine in the treatment of Acanthamoeba infection. The minimal inhibitory concentrations (MICs) of the extract and α-mangostin were assessed in trophozoites with 0.25 and 0.5 mg/mL, for cysts with 4 and 1 mg/mL, respectively. The MIC of the extract and α-mangostin inhibited the growth of A. triangularis trophozoites and cysts for up to 72 h. The extract and α-mangostin combined with chlorhexidine demonstrated good synergism, resulting in a reduction of 1/4-1/16 of the MIC. The SEM results showed that Acanthamoeba cells treated with a single drug and its combination caused damage to the cell membrane and irregular cell shapes. A good combination displayed by the extract or α-mangostin and chlorhexidine, described for the first time. Therefore, this approach is promising as an alternative method for the management of Acanthamoeba infection in the future.

Entities:  

Year:  2021        PMID: 33850179     DOI: 10.1038/s41598-021-87381-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  3 in total

1.  Acanthamoeba mauritaniensis genotype T4D: An environmental isolate displays pathogenic behavior.

Authors:  Daniel Coronado-Velázquez; Angélica Silva-Olivares; Federico Castro-Muñozledo; Luis Fernando Lares-Jiménez; Libia Zulema Rodríguez-Anaya; Mineko Shibayama; Jesús Serrano-Luna
Journal:  Parasitol Int       Date:  2019-10-24       Impact factor: 2.230

2.  Expansion of the molecular and morphological diversity of Acanthamoebidae (Centramoebida, Amoebozoa) and identification of a novel life cycle type within the group.

Authors:  Alexander K Tice; Lora L Shadwick; Anna Maria Fiore-Donno; Stefan Geisen; Seungho Kang; Gabriel A Schuler; Frederick W Spiegel; Katherine A Wilkinson; Michael Bonkowski; Kenneth Dumack; Daniel J G Lahr; Eckhard Voelcker; Steffen Clauß; Junling Zhang; Matthew W Brown
Journal:  Biol Direct       Date:  2016-12-28       Impact factor: 4.540

3.  Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats.

Authors:  Muhammad Taher; Tg Muhamad Faris Syafiq Tg Zakaria; Deny Susanti; Zainul Amiruddin Zakaria
Journal:  BMC Complement Altern Med       Date:  2016-05-21       Impact factor: 3.659

  3 in total
  2 in total

1.  Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts.

Authors:  P López-Barona; C Verdú-Expósito; T Martín-Pérez; N Gómez-Casanova; T Lozano-Cruz; P Ortega; R Gómez; J Pérez-Serrano; I Heredero-Bermejo
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

2.  Inhibition of Candida glabrata Biofilm by Combined Effect of Dendritic Compounds and Amphotericin.

Authors:  Natalia Gómez-Casanova; Alba Torres-Cano; Alba Xiaohe Elias-Rodriguez; Tania Lozano; Paula Ortega; Rafael Gómez; Jorge Pérez-Serrano; José Luis Copa-Patiño; Irene Heredero-Bermejo
Journal:  Pharmaceutics       Date:  2022-07-31       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.